Condition
Antiretroviral Therapy, Highly Active
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07219862Not ApplicableNot Yet Recruiting
Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization
NCT05996094Unknown
Antiretroviral Adherence and Drug-level Monitoring
NCT03187964Not ApplicableCompleted
Xpert Ultra and Xpert HIV-VL in People Living With HIV
NCT02012972CompletedPrimary
Non-Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population
NCT02711293Not ApplicableCompleted
The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression
Showing all 5 trials